Skip to main content

Table 3 Clinical outcomes per pathogen of 505 patients hospitalised with community-acquired pneumonia

From: Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis

  Length of hospital stay (IQR) ICU admission (%) In-hospital mortality (%) 30-day mortality (%) One-year mortality (%)
Streptococcus pneumoniae (n = 124) 8.5 (6.5-14.9) 10 (8.1) 4 (3.2) 4 (3.2) 12 (9.7)
Coxiella burnetii (n = 28) 5.5 (3.5-7.5) 0 0 1 (3.6) 1 (3.6)
Haemophilus Influenzae (n = 27) 9.0 (7.5-14.0) 2 (7.4) 0 0 3 (11.1)
Legionella pneumophila (n = 20) 11.0 (6.5-17.0) 3 (15.0) 1 (5.0) 1 (5.0) 2 (10.0)
Chlamydophila species (n = 16) 8.5 (6.6-13.3) 2 (12.5) 0 0 1 (6.3)
Mycoplasma pneumoniae (n = 9) 5.0 (4.5-7.3) 0 0 0 0
Staphylococcus aureus (n = 9) 10.5 (7.3-14.5) 1 (11.1) 3 (33.3) 3 (33.3) 4 (44.4)
Other pathogen (n = 27) 8.0 (5.0-15.8) 7 (25.9) 2 (7.4) 2 (7.4) 9 (33.3)
Viral pathogen (n = 35) 8.5 (6.3-13.5) 1 (2.9) 2 (5.7) 3 (8.6) 6 (17.1)
No pathogen found (n = 210) 8.5 (5.5-12.6) 12 (5.7) 12 (5.7) 12 (5.7) 35 (16.7)
  1. Data are presented as number (%) or median (IQR). For calculation of median length of stay patients who died during admission where excluded from the analysis.
  2. Abbreviations: ICU intensive care unit, IQR interquartile range, n number.